PROCEPT BioRobotics (PRCT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Voting matters and shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting and until successors are elected and qualified.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory approval of the compensation of named executive officers.
Board of directors and corporate governance
Board recommends a vote FOR all director nominees, FOR auditor ratification, and FOR executive compensation.
Executive compensation and say-on-pay
Shareholders will vote on a non-binding advisory basis to approve the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from PROCEPT BioRobotics
- Q2 revenue up 61% year-over-year, gross margin at 59%, and cash reserves strong at $214.1M.PRCT
Q2 20248 Jul 2026 - Aquablation's clinical success and broad coverage drive rapid adoption and expansion in urology.PRCT
45th Annual William Blair Growth Stock Conference8 Jul 2026 - Q3 2024 revenue up 66% with record gross margin and HYDROS launch driving strong growth.PRCT
Q3 20248 Jul 2026 - Aquablation is poised for leadership in BPH and prostate cancer, with accelerating growth and margin expansion.PRCT
Conference presentation2 Jul 2026 - Operational realignment and clinical innovation drive growth and profitability in BPH and prostate cancer.PRCT
46th Annual William Blair Growth Stock Conference2 Jun 2026 - Revenue, margin, and growth initiatives exceeded targets; new strategies and trials drive future upside.PRCT
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 revenue up 20% to $83.1M, gross margin 65%, net loss widens, guidance strong.PRCT
Q1 20261 May 2026 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance focus.PRCT
Proxy filing23 Apr 2026 - Launch teams, inventory optimization, and HYDROS upgrades set the stage for growth in 2024–2026.PRCT
TD Cowen 46th Annual Health Care Conference2 Mar 2026